CAG
24
-3
ZBH
65
3
VNO
46
-13
PDCO
29
2
XOM
42
-6
MLM
45
-5
AME
74
-4
EL
15
-3
SYF
86
-6
PLD
45
-5
SNA
70
-5
T
48
3
K
51
-3
CMI
64
-3
LH
40
-5
CVS
41
-4
NOV
52
-5
AA
56
15
EOG
56
-2
EXPD
43
-4
CAG
24
-3
ZBH
65
3
VNO
46
-13
PDCO
29
2
XOM
42
-6
MLM
45
-5
AME
74
-4
EL
15
-3
SYF
86
-6
PLD
45
-5
SNA
70
-5
T
48
3
K
51
-3
CMI
64
-3
LH
40
-5
CVS
41
-4
NOV
52
-5
AA
56
15
EOG
56
-2
EXPD
43
-4
Financhill
Back

AtlasClear Holdings Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
35

ATCH
AtlasClear Holdings

Last Price:
0.24
Seasonality Move:
-5.13%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
43.04
Seasonality Move:
17.03%
Sell
35
AtlasClear Holdings (ATCH) is a Sell

Is AtlasClear Holdings a Buy, Sell or Hold?

  • The current AtlasClear Holdings [ATCH] share price is $0.18. The Score for ATCH is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • ATCH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ATCH Stock Price Chart

What is AtlasClear Holdings's stock price today?

  • The AtlasClear Holdings share price today is $0.18
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATCH is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

ATCH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 46.93 Sell
Chaikin Money Flow: 253457 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.15 - 0.21) Sell
Bollinger Bands (100): (0.08 - 0.6) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

ATCH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.21 Sell
20-day SMA: 0.19 Sell
50-day SMA: 0.19 Sell
200-day SMA: 1.18 Sell
8-day EMA: 0.19 Sell
20-day EMA: 0.19 Sell
50-day EMA: 0.23 Sell
200-day EMA: 1.83 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

AtlasClear Holdings Earnings Growth & ATCH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

AtlasClear Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):